Results 251 to 260 of about 168,958 (281)

B lymphocytes and tertiary lymphoid structures have a prognostic impact on penile squamous cell carcinoma. [PDF]

J Pathol Clin Res
Zavillová N, Waldauf P, Kendall Bártů M, Čapka D, Hojný J, Prouzová Z, Matěj R, Zachoval R, Hrudka J.   +8 more
europepmc   +1 more source

A dual diacylglycerol kinase (DGK) alpha/zeta inhibitor augments the activity of human tumor infiltrating lymphocytes in <i>in vivo</i> and <i>ex vivo</i> models. [PDF]

Oncoimmunology
Areesawangkit P, Fong KP, Niemeyer E, Li Y, Markowitz K, Delman D, Krause R, Carl J, Feldman P, Troung L, Hess R, Ren X, Timmers C, Kim S, Brody R, Singhal S, Predina J, Eruslanov E, Beatty G, Melidosian B, Albelda SM.   +20 more
europepmc   +1 more source

CSDE1 depletion inhibits tumor progression through enhancing B-cell infiltration in NSCLC. [PDF]

Cell Death Dis
Li W, Xiang S, Liu K, Wang Y, Li Q, OuYang Q, Zhan Y, Yu B, Chen H, Ge B, Cui J, Yin J, Guo A.   +12 more
europepmc   +1 more source

Editorial: Unveiling the next generation of cancer immunity & immunotherapy. [PDF]

Front Immunol
Sadasivam M, Muniraj N, Thangavel C.
europepmc   +1 more source

FAM135B Deficiency Inhibits Cytotoxic T-cell Activity in Triple-Negative Breast Cancer by Blocking the IFI16-Dependent STING Pathway. [PDF]

Cancer Immunol Res
Lin W, Li J, Wu J, Huang B, Liang J, Zhang Y, Zhao L, Yao G.   +7 more
europepmc   +1 more source

Error in Byline.

JAMA Netw Open
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tumor-Infiltrating Lymphocytes

The Cancer Journal, 2015
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) in combination with lymphodepletion and high-dose interleukin 2 has shown reproducible objective response rates of approximately 50% in patients with highly advanced, refractory metastatic melanoma.
Michal J, Besser, Ronnie, Shapira-Frommer, Jacob, Schachter   +2 more
openaire   +3 more sources

Clonal dynamics of tumor-infiltrating lymphocytes

European Journal of Immunology, 2005
The presence of tumor-infiltrating lymphocytes (TIL) provides important evidence of anti-tumor immunity in vivo. However, TIL are usually not sufficient for inhibiting tumor growth. We explored the spatial and temporal aspects of clonal accumulation of TIL using RT-PCR/single-strand conformation polymorphism analysis.
Rong, Yu, Keishi, Fujio, Hiroyuki, Tahara, Yasuto, Araki, Kazuhiko, Yamamoto   +4 more
openaire   +2 more sources

Tumor-Infiltrating Lymphocyte Therapy

The Cancer Journal, 2015
Autologous adoptive T-cell therapies have made tremendous strides over the last few years with excitement currently being generated by technologies that can reprogram T-cell specificities toward any desired antigen including chimeric antigen receptors and recombinant T-cell receptors.
openaire   +2 more sources